Article History
Received: 17 September 2018
Accepted: 18 September 2018
First Online: 9 October 2018
Compliance with ethical standards
:
: JCH is a clinical trial investigator for a Rhythm Pharmaceuticals sponsored study of a medication to treat the obesity observed in rare genetic disorders. RLA is a consultant to Novo Nordisk. IAM is a member of Scientific Advisory Boards for Mars Inc., Nestle, IKEA, Zaluvida, and a member of the Scientific Advisory Committee on Nutrition for the UK Government’s Public Health England. The remaining author declares that he has no conflict of interest.
Free to read: This content has been made available to all.